as 07-26-2024 4:00pm EST
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, Advanced TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates a majority of its revenue from the People's Republic of China.
Founded: | 2005 | Country: | China |
Employees: | N/A | City: | N/A |
Market Cap: | 977.1K | IPO Year: | 2019 |
Target Price: | N/A | AVG Volume (30 days): | 773.3K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -26.96 | EPS Growth: | N/A |
52 Week Low/High: | $0.94 - $9.38 | Next Earning Date: | 08-19-2019 |
Revenue: | $29,919 | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
SXTC Breaking Stock News: Dive into SXTC Ticker-Specific Updates for Smart Investing
The Telegraph
2 months ago
Motley Fool
2 months ago
AFP
2 months ago
Simply Wall St.
2 months ago
Simply Wall St.
2 months ago
Simply Wall St.
2 months ago
Simply Wall St.
2 months ago
Motley Fool
2 months ago
The information presented on this page, "SXTC China SXT Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.